BIOCALTH CALCIUM SUPPLEMENT 100 MG — DIN 02246431
CALCIUM (CALCIUM HVP CHELATE) : 100 MG · BIOCALTH INTERNATIONAL CORPORATION · TABLET · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is BIOCALTH CALCIUM SUPPLEMENT?
BIOCALTH CALCIUM SUPPLEMENT 100 MG contains CALCIUM (CALCIUM HVP CHELATE) : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 02246431, held by BIOCALTH INTERNATIONAL CORPORATION, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 31-Jul-2006. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
Is there a generic Calcium in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
11 holders have a Canadian DIN containing Calcium, across 13 DINs, of which 0 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| BIOCALTH INTERNATIONAL CORPORATION | 2 | 0 | BIOCALTH CALCIUM POWDER, BIOCALTH CALCIUM SUPPLEMENT | No marketed DIN |
| VITA HEALTH PRODUCTS INC | 2 | 0 | CALCIUM 350 MG (CALCIUM CITRATE) - CAPLET, CALCIUM CITRATE | No marketed DIN |
| CADBURY ADAMS CANADA INC. | 1 | 0 | BODYSMARTS WITH CALCIUM | No marketed DIN |
| GAHLER ENTERPRISES LTD. | 1 | 0 | CALCIUM CITRATE TAB 350MG | No marketed DIN |
| GENERAL NUTRITION CANADA INC. | 1 | 0 | OYSTERSHELL CALCIUM 250MG TABLETS | No marketed DIN |
| HOLISTA HEALTH (CANADA) INC. | 1 | 0 | CALCIUM CITRATE | No marketed DIN |
| MISSION PHARMACAL COMPANY | 1 | 0 | CITRACAL LIQUITAB - EVT | No marketed DIN |
| PURITY LIFE HEALTH PRODUCTS A DIVISION OF SUNOPTA INC. | 1 | 0 | CALCIUM 350 MG (CALCIUM CITRATE) CAPLET | No marketed DIN |
| SEROYAL INTERNATIONAL INC. | 1 | 0 | CALCIUM | No marketed DIN |
| STERIMAX INC | 1 | 0 | CAL-CITRUS | No marketed DIN |
| WN PHARMACEUTICALS LTD. | 1 | 0 | CALCIUM CITRATE 300MG | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 100 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Calcium |
|---|---|
| ATC code | A12AA |
| AHFS class | 88:29.00* ; See footnote |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02246431 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2246431 |
| Brand name | BIOCALTH CALCIUM SUPPLEMENT |
| Generic / active ingredient | CALCIUM (CALCIUM HVP CHELATE) : 100 MG |
| Market authorization holder | BIOCALTH INTERNATIONAL CORPORATION |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A12AA |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A12AA |
| Current status | CANCELLED POST MARKET |
| Status date | 31-Jul-2006 |
| Original market date | 2002-10-15 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
Is Calcium in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Anticipated — reported by PFIZER CANADA ULC, last seen 09 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
0 of 13 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| BIOCALTH CALCIUM POWDER | 336 MG | POWDER | BIOCALTH INTERNATIONAL CORPORATION | CANCELLED POST MARKET | 02247522 |
| BODYSMARTS WITH CALCIUM | 30 MG | TABLET | CADBURY ADAMS CANADA INC. | CANCELLED POST MARKET | 02241312 |
| CAL-CITRUS | 200 MG | TABLET | STERIMAX INC | CANCELLED POST MARKET | 02215276 |
| CALCIUM | 150 MG | CAPSULE | SEROYAL INTERNATIONAL INC. | CANCELLED POST MARKET | 02175584 |
| CALCIUM 350 MG (CALCIUM CITRATE) - CAPLET | 350 MG | TABLET | VITA HEALTH PRODUCTS INC | CANCELLED POST MARKET | 02161710 |
| CALCIUM 350 MG (CALCIUM CITRATE) CAPLET | 350 MG | TABLET | PURITY LIFE HEALTH PRODUCTS A DIVISION OF SUNOPTA INC. | CANCELLED POST MARKET | 02245116 |
| CALCIUM CITRATE | 350 MG | TABLET | HOLISTA HEALTH (CANADA) INC. | CANCELLED POST MARKET | 02246253 |
| CALCIUM CITRATE | 200 MG | TABLET | VITA HEALTH PRODUCTS INC | CANCELLED POST MARKET | 02231961 |
| CALCIUM CITRATE 300MG | 300 MG | TABLET | WN PHARMACEUTICALS LTD. | CANCELLED POST MARKET | 02231833 |
| CALCIUM CITRATE TAB 350MG | 350 MG | TABLET | GAHLER ENTERPRISES LTD. | CANCELLED POST MARKET | 00730521 |
2 · Same class — other molecules in ATC A12AA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Calcium Carbonate | CAL SUPP 500 · CAL SUPP 500 - TAB · CALCITE 500 TAB · CALCIUM · +32 more | 39 | 0 | Not in Canada |
| Calcium (Different Salts In Combination) | CALCIUM 500MG · CALCIUM 650MG TAB · CALCIUM CITRAMATE · CALCIUM INJ · +13 more | 20 | 0 | Not in Canada |
| Calcium Gluconate | CALCIUM GLUCONATE 10% INJ 100MG/ML · CALCIUM GLUCONATE INJ 10% · CALCIUM GLUCONATE INJ 100MG/ML · CALCIUM GLUCONATE INJ USP 10% · +8 more | 16 | 0 | Not in Canada |
| Calcium Lactate | CALCIMAX TAB 324MG · CALCIUM LACTATE 650MG · CALCIUM LACTATE TAB 10GR · CALCIUM LACTATE TAB 324MG · +7 more | 14 | 0 | Not in Canada |
| Calcium | BIOCALTH CALCIUM POWDER · BIOCALTH CALCIUM SUPPLEMENT · BODYSMARTS WITH CALCIUM · CAL-CITRUS · +8 more | 13 | 0 | Not in Canada |
| Calcium Phosphate | CAL GEL CAP 45MG · GELLUCAL CAP 45MG | 2 | 0 | Not in Canada |
| Calcium Chloride | CALCIUM CHLORIDE INJ 10% · CALCIUM CHLORIDE INJECTION 100MG/ML | 2 | 0 | Not in Canada |
| Calcium Glucoheptonate | CALCIUM LIQ ALSI · SIROP DE CALCIUM 625MG/5ML | 2 | 0 | Not in Canada |
| Calcium Citrate Lysine Complex | SOLUBLE CALCIUM CITRATE 1200MG | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC A12A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| A12AX | Calcium, Combinations With Vitamin D And/Or Other Drugs | 152 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.